Approved by the Ministry of Food and Drug Safety for Daewoong Pharmaceutical’s new anti-diabetic drug, Enblo Tab.

The 36th new drug developed in Korea

The Ministry of Food and Drug Safety announced on the 30th that it had approved ‘Enblo Tab’, a treatment for type 2 diabetes developed by Daewoong Pharmaceutical.

As a result, Enblo Tab became. is the 36th new drug developed in Korea.

Enblo tablets are dietary and exercise supplements administered to help control blood sugar in patients with type 2 diabetes.

It lowers blood sugar by preventing the kidneys from reabsorbing glucose, allowing glucose to be excreted in the urine.

The Food and Drug Safety Administration expects that this approval will expand the range of treatment options and treatment opportunities for type 2 diabetes patients.

/happy news

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.